308 related articles for article (PubMed ID: 37302427)
41. ATP2B3 Inhibition Alleviates Erastin-Induced Ferroptosis in HT-22 Cells through the P62-KEAP1-NRF2-HO-1 Pathway.
Guo S; Zhong A; Zhang D; Gao J; Ni Y; Zhao R; Ma W
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298147
[TBL] [Abstract][Full Text] [Related]
42. Activation of the P62-Keap1-NRF2 Pathway Protects against Ferroptosis in Radiation-Induced Lung Injury.
Li X; Chen J; Yuan S; Zhuang X; Qiao T
Oxid Med Cell Longev; 2022; 2022():8973509. PubMed ID: 35847598
[TBL] [Abstract][Full Text] [Related]
43. Copper Exposure Induced Chicken Hepatotoxicity: Involvement of Ferroptosis Mediated by Lipid Peroxidation, Ferritinophagy, and Inhibition of FSP1-CoQ10 and Nrf2/SLC7A11/GPX4 Axis.
Zhong G; Li Y; Ma F; Huo Y; Liao J; Han Q; Hu L; Tang Z
Biol Trace Elem Res; 2024 Apr; 202(4):1711-1721. PubMed ID: 37474886
[TBL] [Abstract][Full Text] [Related]
44. Tiliroside targets TBK1 to induce ferroptosis and sensitize hepatocellular carcinoma to sorafenib.
Yang C; Lu T; Liu M; Yuan X; Li D; Zhang J; Zhou L; Xu M
Phytomedicine; 2023 Mar; 111():154668. PubMed ID: 36657316
[TBL] [Abstract][Full Text] [Related]
45. Upregulation of Nrf2 Signalling and the Inhibition of Erastin-Induced Ferroptosis by Ferulic Acid in MIN6 Cells.
Kose T; Sharp PA; Latunde-Dada GO
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555529
[TBL] [Abstract][Full Text] [Related]
46. Targeting PCSK9 in Liver Cancer Cells Triggers Metabolic Exhaustion and Cell Death by Ferroptosis.
Alannan M; Fatrouni H; Trézéguet V; Dittrich-Domergue F; Moreau P; Siegfried G; Liet B; Khatib AM; Grosset CF; Badran B; Fayyad-Kazan H; Merched AJ
Cells; 2022 Dec; 12(1):. PubMed ID: 36611859
[TBL] [Abstract][Full Text] [Related]
47. Camptothecin Sensitizes Hepatocellular Carcinoma Cells to Sorafenib- Induced Ferroptosis Via Suppression of Nrf2.
Elkateb AS; Nofal S; Ali SA; Atya HB
Inflammation; 2023 Aug; 46(4):1493-1511. PubMed ID: 37171695
[TBL] [Abstract][Full Text] [Related]
48. Ferroptosis: The functions of Nrf2 in human embryonic stem cells.
Babaei-Abraki S; Karamali F; Nasr-Esfahani MH
Cell Signal; 2023 Jun; 106():110654. PubMed ID: 36906163
[TBL] [Abstract][Full Text] [Related]
49. Therapeutic Targeting of the NRF2 Signaling Pathway in Cancer.
Telkoparan-Akillilar P; Panieri E; Cevik D; Suzen S; Saso L
Molecules; 2021 Mar; 26(5):. PubMed ID: 33808001
[TBL] [Abstract][Full Text] [Related]
50. Role and mechanism of ferroptosis in neurological diseases.
Ou M; Jiang Y; Ji Y; Zhou Q; Du Z; Zhu H; Zhou Z
Mol Metab; 2022 Jul; 61():101502. PubMed ID: 35447365
[TBL] [Abstract][Full Text] [Related]
51. Induction of ferroptosis by HO-1 contributes to retinal degeneration in mice with defective clearance of all-trans-retinal.
Chen C; Yang K; He D; Yang B; Tao L; Chen J; Wu Y
Free Radic Biol Med; 2023 Jan; 194():245-254. PubMed ID: 36509314
[TBL] [Abstract][Full Text] [Related]
52. Tagitinin C induces ferroptosis through PERK-Nrf2-HO-1 signaling pathway in colorectal cancer cells.
Wei R; Zhao Y; Wang J; Yang X; Li S; Wang Y; Yang X; Fei J; Hao X; Zhao Y; Gui L; Ding X
Int J Biol Sci; 2021; 17(11):2703-2717. PubMed ID: 34345202
[No Abstract] [Full Text] [Related]
53. Bone marrow mesenchymal stem cells inhibit ferroptosis via regulating the Nrf2-keap1/p53 pathway to ameliorate chronic kidney disease injury in the rats.
Shao L; Fang Q; Shi C; Zhang Y; Xia C; Zhang Y; Wang J; Chen F
J Recept Signal Transduct Res; 2023 Feb; 43(1):9-18. PubMed ID: 36883687
[TBL] [Abstract][Full Text] [Related]
54. A Genome-wide Haploid Genetic Screen Identifies Regulators of Glutathione Abundance and Ferroptosis Sensitivity.
Cao JY; Poddar A; Magtanong L; Lumb JH; Mileur TR; Reid MA; Dovey CM; Wang J; Locasale JW; Stone E; Cole SPC; Carette JE; Dixon SJ
Cell Rep; 2019 Feb; 26(6):1544-1556.e8. PubMed ID: 30726737
[TBL] [Abstract][Full Text] [Related]
55. NRF2: KEAPing Tumors Protected.
Pillai R; Hayashi M; Zavitsanou AM; Papagiannakopoulos T
Cancer Discov; 2022 Mar; 12(3):625-643. PubMed ID: 35101864
[TBL] [Abstract][Full Text] [Related]
56. Targeting ferroptosis for cancer therapy: exploring novel strategies from its mechanisms and role in cancers.
Jiang M; Qiao M; Zhao C; Deng J; Li X; Zhou C
Transl Lung Cancer Res; 2020 Aug; 9(4):1569-1584. PubMed ID: 32953528
[TBL] [Abstract][Full Text] [Related]
57. Striking a NRF2: The Rusty and Rancid Vulnerabilities Toward Ferroptosis in Alzheimer's Disease.
Lane DJR; Alves F; Ayton SJ; Bush AI
Antioxid Redox Signal; 2023 Jul; 39(1-3):141-161. PubMed ID: 37212212
[No Abstract] [Full Text] [Related]
58. Flavonoid 4,4'-dimethoxychalcone induced ferroptosis in cancer cells by synergistically activating Keap1/Nrf2/HMOX1 pathway and inhibiting FECH.
Yang C; Wang T; Zhao Y; Meng X; Ding W; Wang Q; Liu C; Deng H
Free Radic Biol Med; 2022 Aug; 188():14-23. PubMed ID: 35697292
[TBL] [Abstract][Full Text] [Related]
59. Ferroptosis and NRF2: an emerging battlefield in the neurodegeneration of Alzheimer's disease.
Lane DJR; Metselaar B; Greenough M; Bush AI; Ayton SJ
Essays Biochem; 2021 Dec; 65(7):925-940. PubMed ID: 34623415
[TBL] [Abstract][Full Text] [Related]
60. Astragaloside IV mitigates cerebral ischaemia-reperfusion injury via inhibition of P62/Keap1/Nrf2 pathway-mediated ferroptosis.
Wang L; Liu C; Wang L; Tang B
Eur J Pharmacol; 2023 Apr; 944():175516. PubMed ID: 36758783
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
